Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Animal Science and Biotechnology|March 27, 2015
Epigenetics and transgenerational inheritance in domesticated farm animalsAmanda Feeney, Eric Nilsson, Michael K Skinner
Reproduction (Cambridge, England)|June 28, 2014
Cytokine (IL16) and tyrphostin actions on ovarian primordial follicle developmentAmanda Feeney, Eric Nilsson, Michael K Skinner
International Journal of Emergency Medicine|March 15, 2023
Right-sided weakness in a Rwandan patient with untreated Tetralogy of FallotSylvain Tshilombo, Romeo Bilugan, Amanda Feeney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2020
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapyOsnat Elyashiv, Jonathan Ledermann, Gita Parmar, et al.
The Oncologist|June 10, 2017
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyFelicia T Roncolato, Florence Joly, Rachel O'Connell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 18, 2017
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancerMadeleine T King, Martin R Stockler, Rachel L O'Connell, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 28, 2022
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit StudyYeh Chen Lee, Madeleine T King, Rachel L O'Connell, et al.
Gynecologic Oncology|June 19, 2022
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancerRachel Campbell, Daniel S J Costa, Martin R Stockler, et al.
Lancet (London, England)|October 17, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trialMary McCormack, Gemma Eminowicz, Dolores Gallardo, et al.
Pageof 2